Susan Hasty, Publisher
Table of Contents . . . August 4th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Addiction Therapy - Brain Contains Cocaine-Like Chemical with Potential for Treating Addiction
Drug Development - American Mayapple Yields Anti-Cancer Extract
Adverse Drug Effects - Report Urges Closer Look at Cardiotoxicity of Breast Cancer Drug Trastuzumab (Herceptin)
Allergy Medicine - Molecular Structure Key to Allergies and Asthma Identified
Ovarian Cancer - Low-Dose Oral Contraceptives are as Protective as Older, High-Dose Pills
AIDS Therapies - Two Triple Drug Regimens Compared
Alzheimer's Disease - Positive Results from Phase III Memantine Trial Presented
Alzheimer's Disease - Preclinical Results Announced for NCX 2216 Drug
Dietary Supplements - Research Supports Mood-Enhancing Benefits of Dietary Supplement, SAM-e
Nosocomial Infection - Lethal Antibiotic Created to Cause Resistant Bacteria to Self-Destruct
Type 2 Diabetes - Treatment Paradigm Emerges for Patients with Diabetes
AIDS Therapies - Encouraging Clinical Results for HIV Inhibitor Announced
AIDS Therapies - European CPMP Gives Positive Opinion on Triple Combination Therapy
AIDS Therapies - New Clinical Research on Ampligen to be Conducted
AIDS Vaccines - IAVI Issues Blueprint to Assure Global Access
Cancer Therapies - Phase II Studies Initiation for Anti-Cancer Compound Announced
Industry News - Agreement Entered to Identify Therapeutic Targets Through Protein Function Prediction
Industry News - Alliance Formed to Serve Genomics-Driven Drug Discovery
Industry News - Four Central Nervous System Candidate Genes Delivered
Malaria - FDA Approval Announced for Malarone
Myelodysplastic Syndrome - Orphan Drug Designation Received for Arsenic Trioxide
Neuropsychiatric Disease - Phase I SBIR Grant Awarded for Pharmacogenomic Research
Therapy (HCV) - Human Cellular Genes Required for Hepatitis C Virus Protein Synthesis are Identified
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.